News

Article

Recipharm Gains New ISO Certification Recognizing Sustainability Efforts

Recipharm has received ISO 45001 certification for its Wasserberg facility in Germany as a result of the facility’s program to enhance sustainability and safety.

Recipharm, contract development and manufacturing organization (CDMO), has received ISO 45001 certification for its Wasserberg facility in Germany as a result of the facility’s program to enhance sustainability and safety.

ISO 45001 is the new working protection standard from the International Organization for Standardization (ISO), which was developed to improve employee safety, reduce workplace risk, and create better working conditions globally. The certification has been developed from an earlier one according to OSHAS 18001.

“Recipharm is committed to the ongoing development of its sustainability standards,” said Erik Haeffler, VP of Manufacturing Services and head of sustainability, in a Feb. 28, 2019 press release. “Achieving ISO 45001 at our first site demonstrates that we can perform to the highest standards when it comes to occupational health and safety. We now start the roll-out across our other facilities as we work towards ensuring we have management systems in place to manage not only occupational health and safety, but also other areas such as the environmental impact.”

Source: Recipharm

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More